Your session is about to expire
What is Inveltys
LoteprednolThe Generic name of this drug
Alrexis the brand name
Inveltys Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Alrex
Loteprednol
1998
16
Approved as Treatment by the FDA
Loteprednol, otherwise called Alrex, is approved by the FDA for 10 uses like Eye and Herpes Zoster Keratitis .Eye
Herpes Zoster Keratitis
Helps manage Herpes Zoster Keratitis
Iritis
Ocular Inflammation
Inflammation
Used to treat Inflammation in combination with Tobramycin
Conjunctivitis infective
Cyclitis
Seasonal Allergic Conjunctivitis
Superficial punctate keratitis
Helps manage Superficial punctate keratitis
ocular bacterial infections
Used to treat ocular bacterial infections in combination with Tobramycin
When to interrupt dosage
The recommended measure of Inveltys is contingent upon the ascertained condition, including Ocular Inflammation, Conjunctivitis infective and Herpes Zoster Keratitis. The quantity of dosage shifts, as per the technique of delivery (e.g. Gel - Ophthalmic or Suspension/drops) noted in the table beneath.Condition
Dosage
Administration
Chickenpox
, 2.0 mg/mL, 0.005 mg/mg, 5.0 mg/mL, 0.2 %, 0.5 %
, Ophthalmic, Suspension / drops, Suspension / drops - Ophthalmic, Ointment, Ointment - Ophthalmic, Suspension, Suspension - Ophthalmic, Gel, Gel - Ophthalmic
Iritis
, 2.0 mg/mL, 0.005 mg/mg, 5.0 mg/mL, 0.2 %, 0.5 %
, Ophthalmic, Suspension / drops, Suspension / drops - Ophthalmic, Ointment, Ointment - Ophthalmic, Suspension, Suspension - Ophthalmic, Gel, Gel - Ophthalmic
Inflammation
, 2.0 mg/mL, 0.005 mg/mg, 5.0 mg/mL, 0.2 %, 0.5 %
, Ophthalmic, Suspension / drops, Suspension / drops - Ophthalmic, Ointment, Ointment - Ophthalmic, Suspension, Suspension - Ophthalmic, Gel, Gel - Ophthalmic
Eye infection viral
, 2.0 mg/mL, 0.005 mg/mg, 5.0 mg/mL, 0.2 %, 0.5 %
, Ophthalmic, Suspension / drops, Suspension / drops - Ophthalmic, Ointment, Ointment - Ophthalmic, Suspension, Suspension - Ophthalmic, Gel, Gel - Ophthalmic
Rosacea
, 2.0 mg/mL, 0.005 mg/mg, 5.0 mg/mL, 0.2 %, 0.5 %
, Ophthalmic, Suspension / drops, Suspension / drops - Ophthalmic, Ointment, Ointment - Ophthalmic, Suspension, Suspension - Ophthalmic, Gel, Gel - Ophthalmic
Superficial punctate keratitis
, 2.0 mg/mL, 0.005 mg/mg, 5.0 mg/mL, 0.2 %, 0.5 %
, Ophthalmic, Suspension / drops, Suspension / drops - Ophthalmic, Ointment, Ointment - Ophthalmic, Suspension, Suspension - Ophthalmic, Gel, Gel - Ophthalmic
Conjunctivitis infective
, 2.0 mg/mL, 0.005 mg/mg, 5.0 mg/mL, 0.2 %, 0.5 %
, Ophthalmic, Suspension / drops, Suspension / drops - Ophthalmic, Ointment, Ointment - Ophthalmic, Suspension, Suspension - Ophthalmic, Gel, Gel - Ophthalmic
Eye
, 2.0 mg/mL, 0.005 mg/mg, 5.0 mg/mL, 0.2 %, 0.5 %
, Ophthalmic, Suspension / drops, Suspension / drops - Ophthalmic, Ointment, Ointment - Ophthalmic, Suspension, Suspension - Ophthalmic, Gel, Gel - Ophthalmic
Seasonal Allergic Conjunctivitis
, 2.0 mg/mL, 0.005 mg/mg, 5.0 mg/mL, 0.2 %, 0.5 %
, Ophthalmic, Suspension / drops, Suspension / drops - Ophthalmic, Ointment, Ointment - Ophthalmic, Suspension, Suspension - Ophthalmic, Gel, Gel - Ophthalmic
Ocular Inflammation
, 2.0 mg/mL, 0.005 mg/mg, 5.0 mg/mL, 0.2 %, 0.5 %
, Ophthalmic, Suspension / drops, Suspension / drops - Ophthalmic, Ointment, Ointment - Ophthalmic, Suspension, Suspension - Ophthalmic, Gel, Gel - Ophthalmic
Herpes Zoster Keratitis
, 2.0 mg/mL, 0.005 mg/mg, 5.0 mg/mL, 0.2 %, 0.5 %
, Ophthalmic, Suspension / drops, Suspension / drops - Ophthalmic, Ointment, Ointment - Ophthalmic, Suspension, Suspension - Ophthalmic, Gel, Gel - Ophthalmic
Cyclitis
, 2.0 mg/mL, 0.005 mg/mg, 5.0 mg/mL, 0.2 %, 0.5 %
, Ophthalmic, Suspension / drops, Suspension / drops - Ophthalmic, Ointment, Ointment - Ophthalmic, Suspension, Suspension - Ophthalmic, Gel, Gel - Ophthalmic
ocular bacterial infections
, 2.0 mg/mL, 0.005 mg/mg, 5.0 mg/mL, 0.2 %, 0.5 %
, Ophthalmic, Suspension / drops, Suspension / drops - Ophthalmic, Ointment, Ointment - Ophthalmic, Suspension, Suspension - Ophthalmic, Gel, Gel - Ophthalmic
Warnings
Inveltys ContraindicationsCondition
Risk Level
Notes
Severe Hypersensitivity Reactions
Do Not Combine
Loteprednol may interact with Pulse Frequency
Keratitis, Dendritic
Do Not Combine
conjunctiva
Do Not Combine
epithelial herpes simplex
Do Not Combine
Varicella
Do Not Combine
Vaccinia
Do Not Combine
epithelial herpes simplex keratitis
Do Not Combine
Eye Infections, Fungal
Do Not Combine
Common Inveltys Drug Interactions
Drug Name
Risk Level
Description
2,4-thiazolidinedione
Moderate
The risk or severity of hyperglycemia can be increased when Loteprednol is combined with 2,4-thiazolidinedione.
AICA ribonucleotide
Moderate
The risk or severity of hyperglycemia can be increased when Loteprednol is combined with AICA ribonucleotide.
AMG-222
Moderate
The risk or severity of hyperglycemia can be increased when Loteprednol is combined with AMG-222.
Acarbose
Moderate
The risk or severity of hyperglycemia can be increased when Loteprednol is combined with Acarbose.
Acetohexamide
Moderate
The risk or severity of hyperglycemia can be increased when Loteprednol is combined with Acetohexamide.
Inveltys Novel Uses: Which Conditions Have a Clinical Trial Featuring Inveltys?
198 active clinical trials are currently in progress to ascertain the efficacy of Inveltys in alleviating Seasonal Allergic Conjunctivitis, Iritis and Ocular Inflammation.Condition
Clinical Trials
Trial Phases
Conjunctivitis infective
0 Actively Recruiting
Superficial punctate keratitis
0 Actively Recruiting
Eye
0 Actively Recruiting
Seasonal Allergic Conjunctivitis
0 Actively Recruiting
Iritis
0 Actively Recruiting
ocular bacterial infections
0 Actively Recruiting
Inflammation
170 Actively Recruiting
Phase 1, Phase 2, Not Applicable, Early Phase 1, Phase 3, Phase 4
Eye infection viral
0 Actively Recruiting
Cyclitis
0 Actively Recruiting
Herpes Zoster Keratitis
0 Actively Recruiting
Chickenpox
3 Actively Recruiting
Phase 2, Phase 1
Rosacea
8 Actively Recruiting
Not Applicable, Early Phase 1, Phase 2, Phase 4
Ocular Inflammation
3 Actively Recruiting
Phase 2, Phase 4, Phase 3
Inveltys Reviews: What are patients saying about Inveltys?
5Patient Review
2/7/2020 I've been using these eye drops for months, first for post-surgery and later for my dry eye. Applying them twice daily really helped with the swelling and vision. I also found that I didn't have to rub my eyes as much when using inveltys which was a huge plus.
4.3Patient Review
8/2/2021 I'm a few weeks out from surgery and my eyes feel much more relaxed. I tried another product previously that was in gel form, but it felt really uncomfortable. This one works better for me. It's a little pricy, but it's worth trying.
2.3Patient Review
8/29/2022 I wasn't a fan of this bottle. It wasted a lot of product and was difficult to use.
2Patient Review
5/9/2019 surgery was two weeks ago and my eyes are still swollen. Not only that, but my vision has become cloudy. I don't see the appeal of this drug at all.
2Patient Review
5/17/2020 I'm using this medication for the inflammation of my retina following cataract surgery, but I have yet to see any improvement. It's a very expensive drug with little to show for it so far.
Patient Q&A Section about inveltys
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.What is another name for Inveltys?
"Only for ophthalmic use.
Inveltys is an eye drop that contains a steroid. It is used to treat inflammation."
Answered by AI
What are the side effects of Inveltys eye drops?
"The following are symptoms of eye allergies: headaches, burning, eye irritation, itching, dry eyes, blurred eyesight, feeling that something is in the eye, runny nose."
Answered by AI
How long should you use Inveltys after cataract surgery?
"Apply one or two drops of the solution into the affected eye up to four times a day, starting 24 hours after the surgery was performed. Continue using the solution for two weeks."
Answered by AI